Skip to content

Sanara MedTech Inc. SMTI Enterprise value

Enterprise value at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
Stryker logo
StrykerSYK
$137.35B-12.4%
IAR
Integra LifeSciencesIART
$2.47B-26.7%
Solventum logo
SolventumSOLV
$16.56B-19.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$577.67M-23.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$297.01M-7.1%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s enterprise value?
Sanara MedTech Inc. (SMTI) reported enterprise value of $192.26M in Q1 2026.
How has Sanara MedTech Inc.'s enterprise value changed year-over-year?
Sanara MedTech Inc.'s enterprise value decreased by 35.7% year-over-year, from $298.83M to $192.26M.
What is the long-term trend for Sanara MedTech Inc.'s enterprise value?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s enterprise value has grown at a -6.7% compound annual growth rate (CAGR), from $340.18M to $240.26M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.